Posts by Gary Skarja

Gary Skarja

Powering Future Cell and Gene Therapy Manufacturing

Biomanufacturing tools providers play a vital role by developing novel technologies and products to drive down manufacturing costs. This blog discusses 3 areas of technology powering the future of cell and gene therapies (CGT) manufacturing with design and development insights for each area: decentralized manufacturing, closed & automated systems and single-use technologies.

Gary Skarja

BioProcessing 4.0: Building the Future of Bioprocessing

Bioprocessing (also known as biologics manufacturing) is a branch of the medical industry where bacteria, cells or enzymes are used to create and isolate biopharmaceutical products. This is broadly accomplished in multiple upstream (e.g., cell culture, cultivation and harvesting) and downstream (e.g., filtration, centrifugation and chromatography) unit operations in concert with process analytical technology.

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.

Website Survey

Please answer a few questions about our website.

Take Survey No Thanks